Survival Study in Pediatric Patients with Medulloblastoma in a General Hospital in Tehran, Iran
References
- Huang, PI, et al. Large cell/anaplastic medulloblastoma is associated with poor prognosis—A retrospective analysis at a single institute. Childs Nerv Syst, 2017; 33(8):1285–1294.
- Hadi, I, et al. Medulloblastoma in adults: A retrospective single institution analysis. Strahlenther Onkol, 2018; 194(3):225–234.
- Millard, NE, De Braganca, KC. Medulloblastoma. J Child Neurol, 2016; 31(12):1341–1353.
- Kline, CN, et al. Case-based review: Pediatric medulloblastoma. Neurooncol Pract, 2017; 4(3):138–150.
- Nalita, N, et al. Survival and prognostic factors in pediatric patients with medulloblastoma in southern Thailand. J Pediatr Neurosci, 2018; 13(2):150–157.
- Prasad, KSV, et al. Clinicopathological study of pediatric posterior fossa tumors. J Pediatr Neurosci, 2017; 12(3):245–250.
- Bavle, A., Parsons, DW. From one to many: Further refinement of medulloblastoma subtypes offers promise for personalized therapy. Cancer Cell, 2017; 31(6):727–729.
- Ryzhova, MV, et al. Characteristics of medulloblastoma in children under age of three years. Zh Vopr Neirokhir Im N N Burdenko, 2013; 77(1):3–10; discussion 11.
- Gerber, NK, et al. Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols. Int J Radiat Oncol Biol Phys, 2013; 86(1):58–63.
- Ramaswamy, V, et al. Risk stratification of childhood medulloblastoma in the molecular era: The current consensus. Acta Neuropathol, 2016; 131(6):821–831.
- Northcott, PA, et al. Molecular subgroups of medulloblastoma. Expert Rev Neurother, 2012; 12(7):871–884.
- von Stackelberg, A, et al. Toxicity, supportive care and costs of two chemotherapy protocols for treatment of childhood ALL in Russia: BFM 90m and MB 91. Eur J Cancer, 1999; 35(9):1349–1355.
- Menon, G, Krishnakumar, K, Nair, S. Adult medulloblastoma: Clinical profile and treatment results of 18 patients. J Clin Neurosci, 2008; 15(2):122–126.
- De, B, et al. Long-term outcomes of adult medulloblastoma patients treated with radiotherapy. J Neurooncol, 2018; 136(1):95–104.
- Wefers, AK, et al. Subgroup-specific localization of human medulloblastoma based on pre-operative MRI. Acta Neuropathol, 2014; 127(6):931–933.
- Friedrich, C, et al. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: A prospective observational multicentre study. Eur J Cancer, 2013; 49(4):893–903.
- Kunschner, LJ, et al. Survival and recurrence factors in adult medulloblastoma: The M.D. Anderson Cancer Center experience from 1978 to 1998. Neuro Oncol, 2001; 3(3):167–173.
- Massimino, M, et al. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators. Pediatr Blood Cancer, 2013; 60(2):210–216.
- Chan, AW, et al. Adult medulloblastoma: Prognostic factors and patterns of relapse. Neurosurgery, 2000; 47(3):623–631, discussion 631–632.
- Smoll, NR. Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs). Cancer, 2012; 118(5):1313–1322.
- Call, JA, et al. Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma. Am J Clin Oncol, 2014; 37(1):1–7.
Language: English
Page range: 34 - 39
Submitted on: Sep 24, 2020
Accepted on: Apr 22, 2021
Published on: Jul 4, 2022
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2022 Sahel Valadan Tahbaz, Hossein Yahyazadeh, Marzieh Beheshti, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.